CRISPR Medicine

GEG-Tech


Company:
GEG-Tech

Main Focus:
Nanoparticles to delivery genome editors such as Zinc Finger Nuclease, CRISPR/Cas9 system, Prime Editing system or Base Editing system

Company Stage:
Research, Pre-clinical

Technology | Tool:
RNA-One is an unique nanoparticle that provides an exceptionally high level of biosafety without compromising its effectiveness and while embarking large payloads with a potential precision targeting function

Funding Stage:
Part of AdVenture Studio

Location:
Paris, France

Website:
https://www.geg-tech.com/

Contact Name:
Pascale BERTHET

Contact Email:
pascale.berthet@geg-tech.com


GEG Tech has been founded in 2013 in Paris, France. Our R&D team originated from cutting-edge research laboratories, notably the CNRS (the leading French research institution), and the Riken Institute (Japan), cumulating more than 15 years experience in pionneering research on genetic engineering. GEG Tech has designed nanoparticles with a high cargo capacity, combining biosafety and efficacy to deliver genome editing systems. These nanoparticles allow transient expression of genome editing systems, they are very stable due to their biologic components protecting the payload, and the mechanism of cell entry highly efficient.

Downloads

RNA-ONE_TECHNOLOGY-_THE_BEST_CARGO_FOR_in_Vivo_GENE_EDITING_STRATEGIES.pdf

See the full view ...